Co-infection associated with SARS-CoV-2 and their management

Chavda, Vivek P, Patel, Aayushi B., Pandya, Anjali , Vora, Lalitkumar K., Patravale, Vandana, Tambuwala, Zara M., Aljabali, Alaa A. A., Serrano-Aroca, Ángel, Mishra, Vijay and Tambuwala, Murtaza M. (2023) Co-infection associated with SARS-CoV-2 and their management. Future Science OA, 8 (9). ISSN 2056-5623

Full content URL:

Co-infection associated with SARS-CoV-2 and their management
Published manuscript
fsoa-2022-0011.pdf - Whole Document
Available under License Creative Commons Attribution 4.0 International.

Item Type:Article
Item Status:Live Archive


SARS-CoV-2 was discovered in Wuhan, China and quickly spread throughout the world. This deadly virus moved from person to person, resulting in severe pneumonia, fever, chills and hypoxia. Patients are still experiencing problems after recovering from COVID-19. This review covers COVID-19 and associated issues following recovery from COVID-19, as well as multiorgan damage risk factors and treatment techniques. Several unusual illnesses, including mucormycosis, white fungus infection, happy hypoxia and other systemic abnormalities, have been reported in recovered individuals. In children, multisystem inflammatory syndrome with COVID-19 (MIS-C) is identified. The reasons for this might include uncontrollable steroid usage, reduced immunity, uncontrollable diabetes mellitus and inadequate care following COVID-19 recovery.

Keywords:COVID-19, hypoxia
Subjects:A Medicine and Dentistry > A100 Pre-clinical Medicine
A Medicine and Dentistry > A300 Clinical Medicine
Divisions:College of Social Science
ID Code:53317
Deposited On:10 Feb 2023 13:52

Repository Staff Only: item control page